Hemispherx BioPharma Incorporated
News and Blogs
Total : 1 View more »
Hemispherx BioPharma, Inc hit by shareholder lawsuit
www.prlog.org
Hemispherx BioPharma, Inc hit by shareholder lawsuit. Lawsuit on behalf of certain Hemispherx BioPharma, Inc (Public, AMEX:HEB) against Hemispherx BioPharma over alleged securities laws violations – Deadline: January 11, 2010 – Contact the Shareholders Foundation, Inc
http://www.prlog.org/10415985-hemispherx-biopharma-inc-hit-by-shareholder-lawsuit.html
Web Sites
Total : 1 View more »
Webcast Alert: Hemispherx BioPharma, Inc. Announces HEB Presentation at Redchip Partners New York
Philadelphia, PA, Tuesday, April 08, 2003: PHILADELPHIA, April 8, 2003 -- Hemispherx BioPharma, Inc. (Amex: HEB ) announces the following Webcast: What: HEB Presentation at Redchip Partners New York Investor Conference 2003 When: April 8, 2003 @ 8:30 am EDT Where: http://www.firstcallevents.
http://www.hemispherx.net/content/investor/default.asp?goto=162
Web Sites
powered by 
Total : 28 View more »
Hemispherx Defamation Trial Results in Claims of Both Parties Being ...
www.hemispherx.net
Philadelphia, PA, Friday, February 22, 2002: Hemispherx Biopharma, Incorporated (AMEX: HEB) announced today that a jury in the Pennsylvania Common-Pleas Court, based in ...
http://www.hemispherx.net/content/investor/default.asp?goto=107
Court Explains Why Asensio Conduct Entitles Hemisphex to New Trial
www.asensioexposed.com
in the court of common pleas of philadelphia county first judicial district of pennsylvania civil trial division hemispherx biopharma, incorporated: july term, 2000 plaintiff: no ...
IN THE COURT OF COMMON PLEAS OF PHILADELPHIA COUNTY
fjd.phila.gov
in the court of common pleas of philadelphia county first judicial district of pennsylvania civil trial division hemispherx biopharma, incorporated: july term, 2000 plaintiff: no ...
Hemispherx to Present New Clinical Data on Experimental Treatment of ...
www.hemispherx.net
Philadelphia, PA, Wednesday, February 27, 2002: Hemispherx Biopharma, Incorporated (AMEX:HEB) announced today that new clinical data on its lead investigational immunotherapeutic ...
http://www.hemispherx.net/content/investor/default.asp?goto=106